These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22849266)

  • 1. Susceptibility testing methods, resistance and breakpoints: what do these terms really mean?
    Silley P
    Rev Sci Tech; 2012 Apr; 31(1):33-41. PubMed ID: 22849266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement?
    Kahlmeter G
    J Antimicrob Chemother; 2015 Sep; 70(9):2427-39. PubMed ID: 26089441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.
    Espinel-Ingroff A; Turnidge J
    Rev Iberoam Micol; 2016; 33(2):63-75. PubMed ID: 27296911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Resistance, New Antimicrobial Agents  …  but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.
    Humphries RM; Hindler JA
    Clin Infect Dis; 2016 Jul; 63(1):83-8. PubMed ID: 27025822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed method for estimating clinical cut-off (CO
    Turnidge JD; Martinez MN
    Vet J; 2017 Oct; 228():33-37. PubMed ID: 29153105
    [No Abstract]   [Full Text] [Related]  

  • 6. Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.
    Brown D; Canton R; Dubreuil L; Gatermann S; Giske C; MacGowan A; Martinez-Martinez L; Mouton J; Skov R; Steinbakk M; Walton C; Heuer O; Struelens MJ; Diaz Hogberg L; Kahlmeter G
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.
    Brown DF; Wootton M; Howe RA
    J Antimicrob Chemother; 2016 Jan; 71(1):3-5. PubMed ID: 26377864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints.
    Dalhoff A; Ambrose PG; Mouton JW
    Infection; 2009 Aug; 37(4):296-305. PubMed ID: 19629383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
    Cantón R; Canut A; Morosini MI; Oliver A
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUCAST expert rules in antimicrobial susceptibility testing.
    Leclercq R; Cantón R; Brown DF; Giske CG; Heisig P; MacGowan AP; Mouton JW; Nordmann P; Rodloff AC; Rossolini GM; Soussy CJ; Steinbakk M; Winstanley TG; Kahlmeter G
    Clin Microbiol Infect; 2013 Feb; 19(2):141-60. PubMed ID: 22117544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Susceptibility Testing of Bacteria of Veterinary Origin.
    Watts JL; Sweeney MT; Lubbers BV
    Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29600771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European standards for antibiotic susceptibility testing: towards a theoretical consensus.
    Baquero F
    Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):492-5. PubMed ID: 2226478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility testing in Aspergillus species complex.
    Lass-Flörl C
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():49-53. PubMed ID: 24372722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of MIC as the sole criterion in antimicrobial drug dosage regimen design: the need for full characterization of antimicrobial pharmacodynamic profile especially for drug-resistant organisms.
    Gehring R; Riviere JE
    Vet J; 2013 Oct; 198(1):15-8. PubMed ID: 24025153
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility breakpoints: PK-PD and susceptibility breakpoints.
    Ambrose PG
    Treat Respir Med; 2005; 4 Suppl 1():5-11. PubMed ID: 15846151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion.
    Kronvall G; Giske CG; Kahlmeter G
    Int J Antimicrob Agents; 2011 Oct; 38(4):281-90. PubMed ID: 21640560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BSAC standardized disc susceptibility testing method (version 3).
    Andrews JM
    J Antimicrob Chemother; 2004 May; 53(5):713-28. PubMed ID: 15028662
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimating the precision of disc diffusion antibiotic susceptibility data published by the European committee on antimicrobial susceptibility testing.
    Smith P; Kronvall G
    APMIS; 2014 Nov; 122(11):1096-101. PubMed ID: 24730430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.
    Desmet S; Verhaegen J; Glupzcynski Y; Van Eldere J; Melin P; Goossens H; Piérard D; Declercq P; Lagrou K; Boel A; Cartuyvels R; Denis O; Vandewal W; Saegeman V
    Clin Microbiol Infect; 2016 Aug; 22(8):704-10. PubMed ID: 27234934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.